Secteur Regeneron Pharmaceuticals, Inc.

Actions

REGN

US75886F1075

Produits pharmaceutiques

Marché Fermé - Nasdaq 22:00:00 09/07/2026 Varia. 5j. Varia. 1 janv.
667,95 USD +0,76% Graphique intraday de Regeneron Pharmaceuticals, Inc. +2,09% -13,46%
Principaux concurrents
Varia. Varia. 5j. Variation 1 mois Variation 3 mois Varia. 1 janv. Varia. 1an Varia. 3ans Varia. 5ans Varia. 10ans Capi.($)
+0,76%+2,09%+8,40%-13,01%-13,46%+20,88%-3,54%+15,08%+76,54% 67,96 Md
+0,60%-3,08%-4,88%-8,55%+5,41%+45,71%+220,63%+175,16%+266,99% 54,4 Md
-2,10%+0,89%+19,37%-11,71%-28,82%-49,30%-53,47%-55,96%+9,71% 41,74 Md
-2,79%+32,50%+32,50%+32,50%+32,50%+32,50%+32,50%+32,50% - 40,63 Md
+3,74%-4,01%+60,40%+49,30%+159,61%+133,49%-35,59%-67,11% - 30,38 Md
-0,72%-7,96%-0,10%+12,31%+13,02%+49,53%-27,69%-44,46%-20,85% 29,37 Md
+1,07%+1,42%+14,81%+22,24%+20,00%+72,47%+90,95%+44,47%+38,30% 23,68 Md
+3,88%+2,16%+20,65%+1,36%+17,64%+11,78%+201,51%+2,93% - 19,15 Md
+15,12%+16,82%+33,23%+19,40%+17,88%+96,11%+433,87%+40,52% - 17,68 Md
+0,23%+0,08%+10,21%+18,02%+44,05%+63,84%+134,77%+196,11%+331,89% 17,14 Md
+1,38%+1,90%+1,35%+39,16%+36,31%+121,58%+242,43%+281,12%+3 145,76% 12,81 Md
+0,37%+1,66%+3,56%+6,52%+0,91%+0,50%-29,51%-28,28%-34,45% 11,59 Md
-1,11%-1,02%+19,85%+43,71%+50,58%+149,32%+207,70%+438,97% - 10,94 Md
-4,31%-14,65%-8,12%-18,92%-33,26%-29,16%+677,20%+285,85%+4 865,52% 10,64 Md
+1,96%-13,66%+35,65%-9,79%+24,33%+37,16%+333,64%+283,76% - 6,74 Md
+0,80%+0,40%+1,25%+1,34%-15,38%-21,81%-26,21%-57,91%-55,68% 6,21 Md
+4,80%-5,61%+33,70%+91,79%+195,30%+139,44%+380,36%-27,00% - 5,83 Md
-0,18%+9,59%+12,20%-1,46%-7,83%+14,07%+66,07%-35,17% - 5,5 Md
+6,29%-7,57%+9,65%-21,30%-25,27%-25,94%+151,67%+116,93%+125,59% 5,42 Md
+0,29%-1,03%-10,59%-28,15%-38,03%-53,90%-56,30%-77,40% - 5,18 Md
Moyenne +1,50%-1,66%+14,65%+11,24%+22,77%+40,41%+147,05%+76,01%+795,39% 21,15 Md
Moyenne pondérée par Capi. +0,93%-0,95%+15,30%+8,53%+19,19%+39,92%+100,22%+56,59%+420,47%
Biopharmacies
  1. Bourse
  2. Actions
  3. Action REGN
  4. Secteur Regeneron Pharmaceuticals, Inc.